首页> 外国专利> COLLAGEN-BASED HYDROGELS LOADED WITH ZnO QDs/pDNA COMPLEXES AS CORNEAL SUBSTITUES

COLLAGEN-BASED HYDROGELS LOADED WITH ZnO QDs/pDNA COMPLEXES AS CORNEAL SUBSTITUES

机译:ZnO QDs / pDNA复合物作为玉米替代品的胶原蛋白基水合物

摘要

This invention relates to a method of fabricating collagen-based hydrogels loaded with ZnO QDs/pDNA complexes as corneal substitutes. Polycation-modified ZnO Quantum Dots were encapsulated into IPN hydrogels by the adsorption effect of freeze-dried hydrogels. The weight ratio of substitutes and ZnO QDs complex is approximately 425:1. And the weight ratio of ZnO QDs/pDNA is 25:1. This kind of corneal substitutes possess favorable biocompatibility. It is able to induce and promote the regeneration of the cornea and it will degrade along with the regeneration of the cornea. The incorporation of the MPDSAH can enhance the stability of corneal substitutes under the existence of collagenase. ZnO QDs used in this invention can condense DNA effectively and ferry DNA into cells successfully. In the process of transfection, the location and distribution of DNA/vector can be tracked by fluorescence in real time. What's more, the convenience of preparation, long term storage and transportation offers a general method to fabricate a promising corneal substitute.
机译:本发明涉及一种制备载有ZnO QDs / pDNA复合物作为角膜替代物的胶原基水凝胶的方法。通过冻干水凝胶的吸附作用,将聚阳离子改性的ZnO量子点封装到IPN水凝胶中。替代品与ZnO QDs配合物的重量比约为425:1。 ZnO QDs / pDNA的重量比为25:1。这种角膜替代物具有良好的生物相容性。它能够诱导和促进角膜的再生,并且会随着角膜的再生而降解。在胶原酶的存在下,MPDSAH的掺入可以增强角膜替代物的稳定性。用于本发明的ZnO QD可以有效地凝结DNA并将DNA成功引入细胞。在转染过程中,可以通过荧光实时跟踪DNA /载体的位置和分布。而且,制备的便利性,长期储存和运输提供了一种制造有希望的角膜替代物的通用方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号